Stock Rating Upgrade
The Value Trend Rating for Vanda Pharmaceuticals Inc (NASDAQ: VNDA) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock closed at $4.12 on 4/12/24 after a decline of -3.7%. However, trading volume in this decline was exceptionally low at 36% of normal. The stock has declined -16.3% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Vanda Pharmaceuticals has a good Appreciation Score of 76 but a poor Power Rating of 18, with the Low Neutral Value Trend Rating the result.
Be the first to comment